Key Points VanEck Pharmaceutical ETF offers a higher dividend yield and a lower beta profile than VanEck Biotech ETF. VanEck Biotech ETF has delivered a higher 1-year total return, though it shows a significantly deeper 5-year maximum drawdown. VanEck Pharmaceutical ETF has reached $995.9 million in assets under management (AUM), making it more than twice the size of VanEck Biotech ETF. 10 stocks we like better than VanEck ETF Trust - VanEck Pharmaceutical ETF › The primary distinction between VanEck Pharmaceutical ETF (NASDAQ:PPH) and VanEck Biotech ETF (NASDAQ:BBH) lies in their industry concentration and risk profiles, as one targets stable pharmaceutical leaders while the other focuses on biotechnology firms.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.